These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3060353)

  • 21. Non-occupational lead exposure and hypertension in Pakistani adults.
    Rahman S; Khalid N; Zaidi JH; Ahmad S; Iqbal MZ
    J Zhejiang Univ Sci B; 2006 Sep; 7(9):732-7. PubMed ID: 16909475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rats with hypertension induced by in utero exposure to maternal low-protein diets fail to increase blood pressure in response to a high salt intake.
    Langley-Evans SC; Jackson AA
    Ann Nutr Metab; 1996; 40(1):1-9. PubMed ID: 8722301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes.
    Lee BK; Lee GS; Stewart WF; Ahn KD; Simon D; Kelsey KT; Todd AC; Schwartz BS
    Environ Health Perspect; 2001 Apr; 109(4):383-9. PubMed ID: 11335187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in the systolic pressure of rats chronically fed cadmium.
    Perry HM; Erlanger M; Perry EF
    Environ Health Perspect; 1979 Feb; 28():251-60. PubMed ID: 488039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-level exposure to lead, blood pressure, and hypertension in a population-based cohort.
    Gambelunghe A; Sallsten G; Borné Y; Forsgard N; Hedblad B; Nilsson P; Fagerberg B; Engström G; Barregard L
    Environ Res; 2016 Aug; 149():157-163. PubMed ID: 27208466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-level lead exposure, renal function and blood pressure.
    Staessen J
    Verh K Acad Geneeskd Belg; 1995; 57(6):527-74. PubMed ID: 8686371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat.
    Sherman RC; Langley-Evans SC
    Clin Sci (Lond); 2000 Mar; 98(3):269-75. PubMed ID: 10677384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
    Bravo Y; Quiroz Y; Ferrebuz A; Vaziri ND; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F616-23. PubMed ID: 17567935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between blood pressure and environmental exposure to lead and cadmium in Belgium.
    Staessen J; Bruaux P; Claeys-Thoreau F; DePlaen P; Ducoffre G; Lauwerys R; Roels H; Rondia D; Sartor F; Amery A
    Environ Health Perspect; 1988 Jun; 78():127-9. PubMed ID: 3203631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose chronic lead exposure increases systolic arterial pressure and vascular reactivity of rat aortas.
    Silveira EA; Siman FD; de Oliveira Faria T; Vescovi MV; Furieri LB; Lizardo JH; Stefanon I; Padilha AS; Vassallo DV
    Free Radic Biol Med; 2014 Feb; 67():366-76. PubMed ID: 24308934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of lead on vascular reactivity.
    Chai SS; Webb RC
    Environ Health Perspect; 1988 Jun; 78():85-9. PubMed ID: 3060355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between blood lead and blood pressure in the NHANES II survey.
    Schwartz J
    Environ Health Perspect; 1988 Jun; 78():15-22. PubMed ID: 3203634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease.
    Roncal C; Mu W; Reungjui S; Kim KM; Henderson GN; Ouyang X; Nakagawa T; Johnson RJ
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1391-6. PubMed ID: 17715263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated blood pressure in treated hypertensives with low-level lead accumulation.
    Sharp DS; Osterloh J; Becker CE; Smith AH; Holman BL; Fisher JM
    Arch Environ Health; 1989; 44(1):18-22. PubMed ID: 2563647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood lead and blood pressure: some implications for the situation in The Netherlands.
    de Kort WL; Zwennis WC
    Environ Health Perspect; 1988 Jun; 78():67-70. PubMed ID: 3203650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension.
    Rizzi E; Castro MM; Fernandes K; Barbosa F; Arisi GM; Garcia-Cairasco N; Bendhack LM; Tanus-Santos JE; Gerlach RF
    Arch Toxicol; 2009 May; 83(5):439-49. PubMed ID: 18836702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.